Home > Insider Trading > Filing (0001062993-21-007502)

Filing Details

Accession Number:: 0001062993-21-007502
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-08-13 18:35:30
Reporting Period:: 2021-08-12

Accepted Time:: 2021-08-13 18:35:30
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1581280	Twist Bioscience Corp	TWST	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1219039	Keith Crandell	C/O Arch Venture Partners Ix, Llc 8755 W. Higgins Road, Suite 1025 Chicago IL 60631		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-08-12	1,412	$106.93	486	No	4	S	Direct
Common Stock	Disposition	2021-08-12	41,033	$106.98	78,602	No	4	S	Indirect	By Keith L. Crandell Trust
Common Stock	Disposition	2021-08-12	2,555	$107.56	76,047	No	4	S	Indirect	By Keith L. Crandell Trust
Common Stock	Disposition	2021-02-11	286,480	$0.00	440,354	No	4	J	Indirect	By Arch Venture Fund VII, L.P.
Common Stock	Acquisiton	2021-02-11	14,560	$0.00	97,252	No	4	J	Indirect	By Keith L. Crandell Trust
Common Stock	Disposition	2021-02-11	113,520	$0.00	174,584	No	4	J	Indirect	By ARCH Venture Fund VIII Overage, L.P.
Common Stock	Acquisiton	2021-02-11	1	$0.00	97,253	No	4	J	Indirect	By Keith L. Crandell Trust
Common Stock	Disposition	2021-05-13	214,828	$0.00	225,526	No	4	J	Indirect	By ARCH Venture Fund VII, L.P.
Common Stock	Acquisiton	2021-05-13	10,918	$0.00	108,171	No	4	J	Indirect	By Keith L. Crandell Trust
Common Stock	Disposition	2021-05-13	85,172	$0.00	89,412	No	4	J	Indirect	By ARCH Venture Fund VIII Overage, L.P.
Common Stock	Acquisiton	2021-05-13	1	$0.00	108,172	No	4	J	Indirect	By Keith L. Crandell Trust
Common Stock	Disposition	2021-05-19	225,526	$0.00	0	No	4	J	Indirect	By ARCH Venture Fund VII, L.P.
Common Stock	Acquisiton	2021-05-19	11,462	$0.00	119,634	No	4	J	Indirect	By Keith L. Crandell Trust
Common Stock	Disposition	2021-05-19	89,412	$0.00	0	No	4	J	Indirect	By ARCH Venture Fund VIII Overage, L.P.
Common Stock	Acquisiton	2021-05-19	1	$0.00	119,635	No	4	J	Indirect	By Keith L. Crandell Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Indirect	By Keith L. Crandell Trust
No	4	S	Indirect	By Keith L. Crandell Trust
No	4	J	Indirect	By Arch Venture Fund VII, L.P.
No	4	J	Indirect	By Keith L. Crandell Trust
No	4	J	Indirect	By ARCH Venture Fund VIII Overage, L.P.
No	4	J	Indirect	By Keith L. Crandell Trust
No	4	J	Indirect	By ARCH Venture Fund VII, L.P.
No	4	J	Indirect	By Keith L. Crandell Trust
No	4	J	Indirect	By ARCH Venture Fund VIII Overage, L.P.
No	4	J	Indirect	By Keith L. Crandell Trust
No	4	J	Indirect	By ARCH Venture Fund VII, L.P.
No	4	J	Indirect	By Keith L. Crandell Trust
No	4	J	Indirect	By ARCH Venture Fund VIII Overage, L.P.
No	4	J	Indirect	By Keith L. Crandell Trust

Footnotes

Pro-rata distribution of Common Stock held by a limited partnership to its partners for no consideration.
The shares were directly held by ARCH Venture Fund VII, L.P. ("ARCH Fund VII"). The sole general partner of ARCH Fund VII is ARCH Venture Partners VII, L.P. ("ARCH Partners VII"), which may be deemed to be the beneficial owner of the shares held by ARCH Fund VII. The sole general partner of ARCH Partners VII is ARCH Venture Partners VII, LLC ("ARCH VII LLC"), which may be deemed to be the beneficial owner of the shares held by ARCH Fund VII. ARCH Partners VII and ARCH VII LLC disclaim beneficial ownership of such shares, except to the extent of any pecuniary interest therein.
The shares were directly held by ARCH Venture Fund VIII Overage, L.P. ("ARCH Overage"). The sole general partner of ARCH Overage is ARCH Venture Partners VIII, LLC ("ARCH VIII LLC"), which may be deemed to be the beneficial owner of the shares held by ARCH Overage. ARCH VIII LLC disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.
Keith Crandell is a managing director of ARCH VII LLC and ARCH VIII LLC, and may be deemed to beneficially own the shares held by ARCH Fund VII and ARCH Overage. Mr. Crandell disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.
Change in form of ownership of shares previously reported as beneficially owned by the reporting person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.39 to $107.37. The reporting person undertakes to provide to TWST, any security holder of TWST, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (6) and (7) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.405 to $107.70.